| Trial ID: | L0917 |
| Source ID: | NCT01930123
|
| Associated Drug: |
Fructose
|
| Title: |
Impact of Fructose on Metabolism, Energy Homeostasis and MR Biomarkers in Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Drug: intravenous fructose challenge
|
| Outcome Measures: |
Change in metabolism;Change in energy homeostaticChange in MR Biomarkers
|
| Sponsor/Collaborators: |
Manal Abdelmalek
|
| Gender: |
All
|
| Age: |
18 Years75 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
93
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
| Start Date: |
23/08/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 January 2022
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01930123
|
